Free Trial

Galectin Therapeutics (GALT) Insider Trading & Ownership

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)
Free GALT Stock Alerts
$3.70
+0.25 (+7.25%)
(As of 02:16 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media

Galectin Therapeutics (NASDAQ:GALT) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
52.70%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$14,595.42
Number Of
Insiders Selling
(Last 12 Months)
1
Amount Of
Insider Selling
(Last 12 Months)
$65,248.38
Get GALT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Galectin Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GALT Insider Buying and Selling by Quarter

Ad True Market Insiders
The “Next Bitcoin”? 10 CENT Crypto Set to Explode
The man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…
Click For My #1 FREE Crypto for 2024

Galectin Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/24/2024Joel LewisCEOBuy1,000$3.39$3,390.00  
4/22/2024James C CzirrMajor ShareholderSell21,323$3.06$65,248.38  
4/22/2024Kevin D FreemanDirectorBuy2,500$2.98$7,450.00  
1/16/2024Kary EldredDirectorBuy500$1.79$895.00  
7/19/2023Kary EldredDirectorBuy1,598$1.79$2,860.42  
(Data available from 1/1/2013 forward)

GALT Insider Trading Activity - Frequently Asked Questions

Who is on Galectin Therapeutics's Insider Roster?

The list of insiders at Galectin Therapeutics includes Elissa J Schwartz, Fund L.P. 10X, Jack W Callicutt, James C Czirr, Joel Lewis, Kary Eldred, Kevin D Freeman, and Richard A Jr. Zordani. Learn more on insiders at GALT.

What percentage of Galectin Therapeutics stock is owned by insiders?

52.70% of Galectin Therapeutics stock is owned by insiders. Learn more on GALT's insider holdings.

Which Galectin Therapeutics insiders have been buying company stock?

The following insiders have purchased GALT shares in the last 24 months: Jack W Callicutt ($5,280.00), Joel Lewis ($4,910.00), Kary Eldred ($6,788.42), Kevin D Freeman ($28,200.00), and Richard A Jr. Zordani ($12,500.00).

How much insider buying is happening at Galectin Therapeutics?

Insiders have purchased a total of 32,898 GALT shares in the last 24 months for a total of $57,678.42 bought.

Which Galectin Therapeutics insiders have been selling company stock?

The following insider sold GALT shares in the last 24 months: James C Czirr ($65,248.38).

How much insider selling is happening at Galectin Therapeutics?

Insiders have sold a total of 21,323 Galectin Therapeutics shares in the last 24 months for a total of $65,248.38 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:GALT) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The #1 Biotech Stock to Have on Your Radar in 2024…
Huge Alerts
AI finds its first serious application
Wall Street Star
Have You Seen Elon’s New A.I. Device? (Picture Inside)
InvestorPlace
Healthcare Takes A Big Step Forward With The Help Of AI
The Bull Report
Did You Get Your Free Bitcoin Yet?
Crypto Swap Profits
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press